Karen Facey

Summary

Affiliation: Evidence Based Health Pollicy Consultant
Location: Glasgow, Scotland

Publications

  1. ncbi A sequential procedure for a phase II efficacy trial in hypercholesterolemia
    K M Facey
    Department of Applied Statistics, University of Reading, United Kingdom
    Control Clin Trials 13:122-33. 1992
  2. ncbi What principles should govern the use of managed entry agreements?
    Marianne Klemp
    Norwegian Knowledge Centre for the Health Services, Oslo, Norway
    Int J Technol Assess Health Care 27:77-83. 2011
  3. ncbi Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes
    Katrine B Frønsdal
    Norwegian Knowledge Centre for the Health Services, Oslo, Norway
    Int J Technol Assess Health Care 26:309-16. 2010
  4. ncbi Rapid versus full systematic reviews: validity in clinical practice?
    Amber Watt
    Australian Safety and Efficacy Register of New Interventional Procedures ASERNIP S, Stepney, South Australia, Australia
    ANZ J Surg 78:1037-40. 2008
  5. ncbi Harmonization of evidence requirements for health technology assessment in reimbursement decision making
    John Hutton
    York Health Economics Consortium, University of York, Market Square, Heslington, York, UK
    Int J Technol Assess Health Care 24:511-7. 2008
  6. ncbi Virtual community consultation? Using the literature and weblogs to link community perspectives and health technology assessment
    Jackie M Street
    Discipline of Public Health, University of Adelaide, Adelaide, South Australia, Australia
    Health Expect 11:189-200. 2008
  7. ncbi Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment
    Amber Watt
    Royal Australasian College of Surgeons, Australia
    Int J Technol Assess Health Care 24:133-9. 2008
  8. ncbi Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers
    K Facey
    Evidence Based Health Policy Consultant, Drymen, UK
    Health Technol Assess 11:iii-iv, xi-267. 2007
  9. ncbi Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641
    Finn Børlum Kristensen
    Eur J Nucl Med Mol Imaging 31:295-7; author reply 297-8; discussion 298. 2004
  10. ncbi Investing in new technology: the PET experience
    I Bradbury
    NHS Quality Improvement Scotland, Delta House, 50 West Nile Street, Glasgow G1 2NP, UK
    Br J Cancer 89:224-7. 2003

Detail Information

Publications19

  1. ncbi A sequential procedure for a phase II efficacy trial in hypercholesterolemia
    K M Facey
    Department of Applied Statistics, University of Reading, United Kingdom
    Control Clin Trials 13:122-33. 1992
    ..The accuracy of the error rates of the triangular test using this parameterization is compared with the test based on the difference between the means...
  2. ncbi What principles should govern the use of managed entry agreements?
    Marianne Klemp
    Norwegian Knowledge Centre for the Health Services, Oslo, Norway
    Int J Technol Assess Health Care 27:77-83. 2011
    ....
  3. ncbi Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes
    Katrine B Frønsdal
    Norwegian Knowledge Centre for the Health Services, Oslo, Norway
    Int J Technol Assess Health Care 26:309-16. 2010
    ..In 2009, the HTAi Policy Forum considered how health technology assessment (HTA) could be improved to optimize the use of technologies (in terms of uptake, change in use, or disinvestment) in such complex systems...
  4. ncbi Rapid versus full systematic reviews: validity in clinical practice?
    Amber Watt
    Australian Safety and Efficacy Register of New Interventional Procedures ASERNIP S, Stepney, South Australia, Australia
    ANZ J Surg 78:1037-40. 2008
    ....
  5. ncbi Harmonization of evidence requirements for health technology assessment in reimbursement decision making
    John Hutton
    York Health Economics Consortium, University of York, Market Square, Heslington, York, UK
    Int J Technol Assess Health Care 24:511-7. 2008
    ..This study draws on experiences from recent initiatives intended to promote the harmonization of HTA and experience from related fields, particularly regulatory approval of new medical technologies...
  6. ncbi Virtual community consultation? Using the literature and weblogs to link community perspectives and health technology assessment
    Jackie M Street
    Discipline of Public Health, University of Adelaide, Adelaide, South Australia, Australia
    Health Expect 11:189-200. 2008
    ..Yet HTA methodologists have been slow to include outcomes of these forms of inquiry in analyses, in part because collecting community views is time-consuming and resource intensive...
  7. ncbi Rapid reviews versus full systematic reviews: an inventory of current methods and practice in health technology assessment
    Amber Watt
    Royal Australasian College of Surgeons, Australia
    Int J Technol Assess Health Care 24:133-9. 2008
    ....
  8. ncbi Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers
    K Facey
    Evidence Based Health Policy Consultant, Drymen, UK
    Health Technol Assess 11:iii-iv, xi-267. 2007
    ..Management decisions relating to diagnosis, staging/restaging, recurrence, treatment response and radiotherapy (RT) planning were evaluated separately...
  9. ncbi Health technology assessment of PET in oncology: re Eur J Nucl Med Mol Imaging 2003; 30:637-641
    Finn Børlum Kristensen
    Eur J Nucl Med Mol Imaging 31:295-7; author reply 297-8; discussion 298. 2004
  10. ncbi Investing in new technology: the PET experience
    I Bradbury
    NHS Quality Improvement Scotland, Delta House, 50 West Nile Street, Glasgow G1 2NP, UK
    Br J Cancer 89:224-7. 2003
    ....
  11. ncbi The impact that group sequential tests would have made on ECOG clinical trials
    K M Facey
    Stat Med 9:853-4. 1990
  12. ncbi An improved approximation for calculation of confidence intervals after a sequential clinical trial
    K M Facey
    Department of Applied Statistics, University of Reading, Whiteknights
    Stat Med 9:1277-85. 1990
    ..Accuracy of such confidence intervals after a triangular test is investigated by simulation of coverage probabilities, individual confidence limit probabilities and p-value curves...
  13. ncbi Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group
    A C Collier
    University of Washington School of Medicine, Seattle 98122, USA
    N Engl J Med 334:1011-7. 1996
    ..We studied the safety and efficacy of saquinavir, an HIV-protease inhibitor, given with one or two nucleoside antiretroviral agents, as compared with the safety and efficacy of a combination of two nucleosides alone...
  14. ncbi Comparison of the spending function method and the Christmas tree correction for group sequential trials
    N Stallard
    Department of Applied Statistics, University of Reading, England
    J Biopharm Stat 6:361-73. 1996
    ..For the O'Brien and Fleming test, the spending function method is found to achieve the required error rates more accurately than the Christmas tree correction, while for the triangular test, both methods perform as planned...
  15. ncbi Statistical shortcomings in licensing applications
    J A Lewis
    Medicines Control Agency, Market Towers, London, U K
    Stat Med 17:1663-73. 1998
    ..Inadequacies in reporting statistical work are commonplace. Examples of all these shortcomings are provided and emphasis is placed on the value of a statistical contribution to overall summaries such as the clinical expert report...
  16. ncbi The management of interim analyses in drug development
    K M Facey
    Licensing Division, Medicines Control Agency, London, U K
    Stat Med 17:1801-9; discussion 1811-2. 1998
    ..Aspects of design, conduct, analysis and dissemination of results are considered, with particular focus on the effective use of data monitoring committees in confirmatory efficacy trials...
  17. ncbi A randomized controlled trial of a protease inhibitor (saquinavir) in combination with zidovudine in previously untreated patients with advanced HIV infection
    S Vella
    Laboratory of Virology, Istituto Superiore di Sanita, Rome, Italy
    Antivir Ther 1:129-40. 1996
    ..The combination of drugs with different mechanisms of action represents an advance in the treatment of HIV infection...
  18. ncbi Patient-focused HTAs
    Karen M Facey
    Int J Technol Assess Health Care 27:273-4. 2011
  19. ncbi Patients' perspectives in health technology assessment: a route to robust evidence and fair deliberation
    Karen Facey
    HTAi Interest Group on Patient Citizen Involvement in HTA and University of Glasgow, Glasgow G12 8RZ, United Kingdom
    Int J Technol Assess Health Care 26:334-40. 2010
    ..This should allow two-way flow of information, so that the views of patients are obtained in a supportive way and fed into decision-making processes in a transparent manner...